Lonza Edges Into New Frontier With Singapore Cell Therapy Facility
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Swiss-based contract manufacturer Lonza marked the groundbreaking of its new $28.7 million cell therapy facility in Singapore Sept. 9